332 related articles for article (PubMed ID: 29563324)
1. Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the
Domon Y; Arakawa N; Inoue T; Matsuda F; Takahashi M; Yamamura N; Kai K; Kitano Y
J Pharmacol Exp Ther; 2018 Jun; 365(3):573-582. PubMed ID: 29563324
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige
Kitano Y; Kai K; Yamamura N; Yoshiba S; Kuroha M
Nihon Yakurigaku Zasshi; 2019; 154(6):352-361. PubMed ID: 31787689
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of mirogabalin, a novel ligand for α
Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951
[TBL] [Abstract][Full Text] [Related]
4. Effects of mirogabalin, a novel ligand for the α₂δ subunit of voltage-gated calcium channels, on N-type calcium channel currents of rat dorsal root ganglion culture neurons.
Kitano Y; Wakimoto S; Tamura S; Kubota K; Domon Y; Arakawa N; Saito M; Sava B; Buisson B
Pharmazie; 2019 Mar; 74(3):147-149. PubMed ID: 30961679
[TBL] [Abstract][Full Text] [Related]
5. Mirogabalin activates the descending noradrenergic system by binding to the α
Oyama M; Watanabe S; Iwai T; Tanabe M
J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653
[TBL] [Abstract][Full Text] [Related]
6. A review of a new voltage-gated Ca
Kato J; Inoue T; Yokoyama M; Kuroha M
Expert Opin Pharmacother; 2021 Dec; 22(17):2311-2322. PubMed ID: 34431423
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic effects of the novel α
Murasawa H; Kobayashi H; Saeki K; Kitano Y
Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584
[TBL] [Abstract][Full Text] [Related]
8. Mirogabalin-A Novel Selective Ligand for the α2δ Calcium Channel Subunit.
Zajączkowska R; Mika J; Leppert W; Kocot-Kępska M; Malec-Milewska M; Wordliczek J
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33572689
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury.
Domon Y; Kitano Y; Makino M
Pharmazie; 2018 Nov; 73(11):659-661. PubMed ID: 30396385
[TBL] [Abstract][Full Text] [Related]
10. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study.
Tetsunaga T; Tetsunaga T; Nishida K; Misawa H; Takigawa T; Yamane K; Tsuji H; Takei Y; Ozaki T
J Orthop Surg Res; 2020 May; 15(1):191. PubMed ID: 32456647
[TBL] [Abstract][Full Text] [Related]
11. The Novel Gabapentinoid Mirogabalin Prevents Upregulation of α2δ-1 Subunit of Voltage-Gated Calcium Channels in Spinal Dorsal Horn in a Rat Model of Spinal Nerve Ligation.
Domon Y; Kobayashi N; Kubota K; Kitano Y; Ueki H; Shimojo Y; Ishikawa K; Ofune Y
Drug Res (Stuttg); 2023 Jan; 73(1):54-60. PubMed ID: 36216339
[TBL] [Abstract][Full Text] [Related]
12. Mirogabalin besylate in the treatment of neuropathic pain.
Burgess J; Javed S; Frank B; Malik RA; Alam U
Drugs Today (Barc); 2020 Feb; 56(2):135-149. PubMed ID: 32163529
[TBL] [Abstract][Full Text] [Related]
13. Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain.
Hutmacher MM; Frame B; Miller R; Truitt K; Merante D
J Clin Pharmacol; 2016 Jan; 56(1):67-77. PubMed ID: 26073181
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like effects of mirogabalin, a novel ligand for α
Murasawa H; Kobayashi H; Yasuda SI; Saeki K; Domon Y; Arakawa N; Kubota K; Kitano Y
Pharmacol Rep; 2020 Jun; 72(3):571-579. PubMed ID: 32270470
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and Mechanism of Action of HSK16149, a Selective Ligand of
Gou X; Yu X; Bai D; Tan B; Cao P; Qian M; Zheng X; Chen L; Shi Z; Li Y; Ye F; Liang Y; Ni J
J Pharmacol Exp Ther; 2021 Mar; 376(3):330-337. PubMed ID: 33293377
[TBL] [Abstract][Full Text] [Related]
16. Analgesic characteristics of a newly developed α
Komatsu S; Nakamura S; Nonaka T; Yamada T; Yamamoto T
Mol Pain; 2021; 17():17448069211052167. PubMed ID: 34823399
[TBL] [Abstract][Full Text] [Related]
17. (L)-Phenylglycine, but not necessarily other alpha2delta subunit voltage-gated calcium channel ligands, attenuates neuropathic pain in rats.
Lynch JJ; Honore P; Anderson DJ; Bunnelle WH; Mortell KH; Zhong C; Wade CL; Zhu CZ; Xu H; Marsh KC; Lee CH; Jarvis MF; Gopalakrishnan M
Pain; 2006 Nov; 125(1-2):136-42. PubMed ID: 16781071
[TBL] [Abstract][Full Text] [Related]
18. Mirogabalin, a novel ligand for α
Murasawa H; Pawlak A; Kobayashi H; Saeki K; Yasuda SI; Kitano Y
Biomed Pharmacother; 2021 Jul; 139():111647. PubMed ID: 33940507
[TBL] [Abstract][Full Text] [Related]
19. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
Horga de la Parte JF; Horga A
Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of mirogabalin for the treatment of post-herpetic neuralgia in Taiwan.
Ye X; Gray E; Wang YF; Wang SJ
J Med Econ; 2020 May; 23(5):529-536. PubMed ID: 31971469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
